Stem cell research is often lumped in with other political controversies, like the war in Iraq or the nation's healthcare woes, and opposing groups and activists debate its existence.
Yet Invitrogen - a life sciences giant with revenues of $1.3 billion, business in 70 countries, and about 4,700 employees worldwide - has not only remained unscathed by controversy, but also has been hugely successful due to a strategic communications plan. The Carlsbad, CA-based company, which sells tools used in the ...